Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

Yesterday I posted about prior EUA approval time frames. I just found this today.

On May 28th, 2021 Humanigen Submitted Application to FDA for Emergency Use Authorization for Lenzilumab in COVID-19. Their application is based upon positive results from a trial. They have not received feedback yet.

Aviptadil was submitted May 31st. No news yet either.

Given they filed only 3 days apart presents an interesting situation. If news on Humanigen comes out first you can bet that Aviptadil news will be right behind them. That truly will be your last best time to add either RLFTF or NXRP if you have any dry powder. But don't hesitate, as we will not be the only ones that have this figured out.~ rk, Y@h00 finance conversations